Continuous infusion
Slow, sustained delivery of a peptide over an extended period using an infusion pump or IV drip. Used in clinical settings for NAD+ infusions and some research peptides.
Frequently Asked Questions
What is Continuous infusion?
Slow, sustained delivery of a peptide over an extended period using an infusion pump or IV drip. Used in clinical settings for NAD+ infusions and some research peptides.
Why is Continuous infusion important in peptide research?
Understanding continuous infusion is essential for safe and effective peptide use. Proper administration technique directly impacts peptide bioavailability, therapeutic outcomes, and minimizes the risk of adverse effects or contamination.
Related Terms
Bolus injection
A single, relatively rapid injection of a peptide as opposed to a slow infusion. Most subcutaneous peptide administrations are bolus injections.
Intravenous injectionAn injection directly into a vein, providing immediate systemic bioavailability. Rarely used for self-administered peptides but common in clinical settings for research peptides and NAD+ infusions.
Steady stateThe condition where the rate of peptide administration equals the rate of elimination, resulting in consistent plasma levels. Typically reached after 4–5 half-lives of regular dosing.